<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911002-0071</DOCNO><DOCID>911002-0071.</DOCID><HL>   Business Brief -- Marquest Medical Products Inc.:   Lawsuit Alleging Violations   Of FDA Rules Is Settled</HL><DATE>10/02/91</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   MMPI</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>MEDICAL SUPPLIES, EYEGLASS MANUFACTURERS (MDS)</IN><GV>FOOD AND DRUG ADMINISTRATION (FDA)JUSTICE DEPARTMENT (JUS)</GV><RE>COLORADO (CO)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   Marquest Medical Products Inc., Englewood, Colo., said itsigned a consent decree with the U.S. Justice Department,settling a lawsuit charging that its manufacturing proceduresviolated Food and Drug Administration guidelines.   The maker of medical products said it didn't admit to anyviolations under the settlement. But it said the decree callsfor the FDA to inspect the company to determine if itcomplies with good manufacturing practices and otherregulations.</LP><TEXT>   The FDA sued Marquest in August, charging that itsmonitoring procedures differed so greatly from regulationsthat the safety and effectiveness of its products was inquestion. The company last week said it would suspend allshipments while it negotiated with the FDA.   Yesterday, Marquest said it won't resume shipments untilthe FDA inspections are complete.</TEXT></DOC>